Detalles de la búsqueda
1.
Metabolomics as a tool to predict the risk of decompensation or liver-related death in patients with compensated cirrhosis.
Hepatology;
77(6): 2052-2062, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36811400
2.
Implementation of a re-linkage to care strategy in patients with chronic hepatitis C who were lost to follow-up in Latin America.
J Viral Hepat;
30(1): 56-63, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36197907
3.
Performance of pre-transplant criteria in prediction of hepatocellular carcinoma progression and waitlist dropout.
Liver Int;
42(8): 1879-1890, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35304813
4.
Failure in all steps of hepatocellular carcinoma surveillance process is frequent in daily practice.
Ann Hepatol;
25: 100344, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33819695
5.
LI-RADS 4 or 5 categorization may not be clinically relevant for decision-making processes: A prospective cohort study.
Ann Hepatol;
19(6): 662-667, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32683095
6.
SARS-CoV-2 vaccination in liver transplant recipients: We still haven't found what we are looking for.
Ann Hepatol;
28(3): 101081, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36882137
7.
Liver transplant outcomes during the COVID-19 pandemic.
Ann Hepatol;
27(2): 100656, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34954071
8.
Lenvatinib as first-line therapy for recurrent hepatocellular carcinoma after liver transplantation: Is the current evidence applicable to these patients?
World J Transplant;
10(11): 297-306, 2020 Nov 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-33312891
Resultados
1 -
8
de 8
1
Próxima >
>>